NH1,902.90

Narayana Hrudayalaya Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHFORTISNEULANDLABNATCOPHARMLALPATHLABSAILIFECOHANCEMcap ₹38,888 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt1,443.72,213.44,866.14,866.1
Net Debt340.2776.13,681.73,681.7
Total Debt/Equity0.500.611.071.07
Net Debt/Equity0.120.210.810.81
Total Debt/EBITDA1.251.733.013.01
Net Debt/EBITDA0.300.612.282.10
Interest Coverage (EBIT/Interest)9.406.824.804.80
Total Debt/Total Capital %33.3537.8951.7451.74
As Filed — company-reported covenants
Debt/Equity (as filed)1.000.671.291.24
Debt Service Coverage (as filed)3.002.512.362.23
Interest Service Coverage (as filed)10.007.394.974.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.